EUVIMEDEUVIMED entdecken
Open Access

Injectable nanoengineered adhesive hydrogel for treating enterocutaneous fistulas

Natan Roberto de Barros, Ankit Gangrade, Ahmad Elsebahy, RunRun Chen, Fatemeh Zehtabi, Menekse Ermis, Natashya Falcone, Reihaneh Haghniaz, Safoora Khosravi, Alejandro Gomez, Shuyi Huang, Marvin Mecwan und 7 weitere

Acta Biomaterialia · 2024-01 · 173 · 231-246

DOI: 10.1016/j.actbio.2023.10.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-01. Verfasst von Natan Roberto de Barros und 18 weiteren Autor:innen. Beteiligte Einrichtung: Terasaki Institute for Biomedical Innovation (TIBI), 1018 Westwood Blvd, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Tissue Adhesives, Intestinal Fistula. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enterocutaneous fistula (ECF) is a severe medical condition where an abnormal connection forms between the gastrointestinal tract and skin. ECFs are, in most cases, a result of surgical complications such as missed enterotomies or anastomotic leaks. The constant leakage of enteric and fecal contents from the fistula site leads to skin breakdown and increases the risk of infection. Despite advances in surgical techniques and postoperative management, ECF accounts for significant mortality rates, estimated between 15-20%, and causes debilitating morbidity. Therefore, there is a critical need for a simple and effective method to seal and heal ECF. Injectable hydrogels with combined properties of robust mechanical properties and cell infiltration/proliferation have the potential to block and heal ECF. Herein, we report the development of an injectable nanoengineered adhesive hydrogel (INAH) composed of a synthetic nanosilicate (Laponite®) and a gelatin-dopamine conjugate for treating ECF. The hydrogel undergoes fast cross-linking using a co-injection method, resulting in a matrix with improved mechanical and adhesive properties. INAH demonstrates appreciable blood clotting abilities and is cytocompatible with fibroblasts. The adhesive properties of the hydrogel are demonstrated in ex vivo adhesion models with skin and arteries, where the volume stability in the hydrated internal environment facilitates maintaining strong adhesion. In vivo assessments reveal that the INAH is biocompatible, supporting cell infiltration and extracellular matrix deposition while not forming fibrotic tissue. These findings suggest that this INAH holds promising translational potential for sealing and healing ECF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue AdhesivesIntestinal FistulaHumansHydrogelsAdhesivesGelatin

Stichwörter der Autor:innen

Enterocutaneous Fistulaadhesivedopaminegelatinhydrogelnanosilicate

Substanzen

HydrogelsAdhesivesGelatinTissue Adhesives

Autor:innen und Institutionen

  • Terasaki Institute for Biomedical Innovation (TIBI), 1018 Westwood Blvd, Los Angeles, California, USA.
  • Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), Pohang, Gyeongbuk, 37673, Republic of Korea.
  • College of Pharmacy, Korea University, Sejong, Republic of Korea, 30019.
  • Department of Translational Research, Western University of Health Sciences, Pomona, CA 91766, USA.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • National Research Foundation of Korea
  • National Aeronautics and Space Administration
  • Korea Ministry of Science and ICT
  • Terasaki Institute for Biomedical Innovation
  • Korea University
  • Ministry of Education

Zitieren

APA

de Barros, N. R., Gangrade, A., Elsebahy, A., Chen, R., Zehtabi, F., Ermis, M., Falcone, N., Haghniaz, R., Khosravi, S., Gomez, A., Huang, S., Mecwan, M., Khorsandi, D., Lee, J., Zhu, Y., Li, B., Kim, H., Thankam, F. G., & Khademhosseini, A. (2024). Injectable nanoengineered adhesive hydrogel for treating enterocutaneous fistulas. Acta Biomaterialia, 173, 231-246. https://doi.org/10.1016/j.actbio.2023.10.026

Vancouver

de Barros NR, Gangrade A, Elsebahy A, Chen R, Zehtabi F, Ermis M, et al. Injectable nanoengineered adhesive hydrogel for treating enterocutaneous fistulas. Acta Biomaterialia. 2024;173:231-246. doi:10.1016/j.actbio.2023.10.026

BibTeX
@article{deBarros2024,
  author = {de Barros, Natan Roberto and Gangrade, Ankit and Elsebahy, Ahmad and Chen, RunRun and Zehtabi, Fatemeh and Ermis, Menekse and Falcone, Natashya and Haghniaz, Reihaneh and Khosravi, Safoora and Gomez, Alejandro and Huang, Shuyi and Mecwan, Marvin and Khorsandi, Danial and Lee, Junmin and Zhu, Yangzhi and Li, Bingbing and Kim, HanJun and Thankam, Finosh G and Khademhosseini, Ali},
  title = {Injectable nanoengineered adhesive hydrogel for treating enterocutaneous fistulas},
  journal = {Acta Biomaterialia},
  year = {2024},
  volume = {173},
  pages = {231--246},
  doi = {10.1016/j.actbio.2023.10.026}
}
Kostenlos starten →